Aniruddha Datta, M. Pharma., Ph.D.
Vice President of International Operations
Dr. Datta oversees contract research and international manufacturing operations at Haus with a focus on herbal and nutraceutical product development, guiding products from raw material sourcing to finished formulation. His expertise informed key aspects of the Nanocur development program and contributed to its technical refinement and advancement within Haus Bioceuticals. Backed by over three decades of experience, he previously spent 17 years at Panacea Biotec, where he played a pivotal role in setting up laboratories and herbal extraction plants, led the development and launch of India's first herbal drug approved by the Drug Authority, and formulated numerous herbal OTCs, nutraceuticals, cosmeceuticals, and supplements for global markets. At Bambino Group, as Vice President R&D, he established their research infrastructure and directed the development of a broad range of functional food and dietary supplement products. Dr. Datta has conducted research on over 45 medicinal plants, developed novel extraction and purification processes for phytochemical markers, and is credited with 11 patents and 14 publications.